VC
TWST icon

Vestor Capital’s Twist Bioscience TWST Stock Holding History

Vestor Capital’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$69K Buy
+413
New +$26.9K ﹤0.01% 233

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Vestor Capital's TWST Position: Q2 2026 in Review

Vestor Capital opened a new position in Twist Bioscience (TWST) in Q2 2026: 413 shares worth $69K. The stake represents ﹤0.01% of the portfolio and ranks #233 among its holdings.

335 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Vestor Capital held 413 shares of Twist Bioscience worth $69K as of Q2 2026.
  • Twist Bioscience was a new Vestor Capital position in Q2 2026.
  • Twist Bioscience made up ﹤0.01% of Vestor Capital's portfolio in Q2 2026, its #233 holding.
  • 335 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Vestor Capital's 13F filing for Q2 2026, filed 28 Jul 2026.